ImmunoGen, Inc. EBITDA 2010-2023 | IMGN
ImmunoGen, Inc. ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| ImmunoGen, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-219 |
| 2021 | $-123 |
| 2020 | $-20 |
| 2019 | $-88 |
| 2018 | $-154 |
| 2017 | $-53 |
| 2016 | $ |
| 2016 | $-120 |
| 2015 | $-49 |
| 2014 | $-67 |
| 2013 | $-68 |
| 2012 | $-69 |
| 2011 | $-55 |
| 2010 | $-47 |
| 2009 | $-28 |
| ImmunoGen, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $26 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-42 |
| 2022-12-31 | $-59 |
| 2022-09-30 | $-77 |
| 2022-06-30 | $-61 |
| 2022-03-31 | $-22 |
| 2021-12-31 | $-34 |
| 2021-09-30 | $-34 |
| 2021-06-30 | $-27 |
| 2021-03-31 | $-28 |
| 2020-12-31 | $37 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-18 |
| 2020-03-31 | $-23 |
| 2019-12-31 | $9 |
| 2019-09-30 | $-17 |
| 2019-06-30 | $-40 |
| 2019-03-31 | $-40 |
| 2018-12-31 | $-39 |
| 2018-09-30 | $-44 |
| 2018-06-30 | $-36 |
| 2018-03-31 | $-34 |
| 2017-12-31 | $-8 |
| 2017-09-30 | $-30 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-11 |
| 2016-12-31 | |
| 2016-09-30 | $-37 |
| 2016-06-30 | $-34 |
| 2016-03-31 | $-26 |
| 2015-12-31 | $19 |
| 2015-09-30 | $-29 |
| 2015-06-30 | |
| 2015-03-31 | $-17 |
| 2014-12-31 | $50 |
| 2014-09-30 | $-22 |
| 2014-06-30 | |
| 2014-03-31 | $-34 |
| 2013-12-31 | $31 |
| 2013-09-30 | $-11 |
| 2013-06-30 | |
| 2013-03-31 | $2 |
| 2012-12-31 | $4 |
| 2012-09-30 | $-25 |
| 2012-06-30 | |
| 2012-03-31 | $-16 |
| 2011-12-31 | $9 |
| 2011-09-30 | $-19 |
| 2011-06-30 | |
| 2011-03-31 | $-12 |
| 2010-12-31 | $5 |
| 2010-09-30 | $-13 |
| 2010-06-30 | |
| 2010-03-31 | $-9 |
| 2009-12-31 | $4 |
| 2009-09-30 | $-13 |
| 2009-06-30 | |
| 2009-03-31 | $-1 |
